ArticlePregnancy (Hoboken, N.J.)2025
Society for Maternal-Fetal Medicine Position Statement: Prioritizing and investing in pregnancy research.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To effectively address maternal mortality, severe maternal morbidity, and health equity, it is critical that the federal government, industry, and philanthropic foundations prioritize investment in and expansion of pregnancy and postpartum research, including clinical trials during pregnancy and the postpartum period. Improving health before, during, and after pregnancy has the potential to benefit pregnant people, neonates, and families through subsequent generations. The Society for Maternal-Fetal Medicine (SMFM) urges: Federal policymakers to prioritize and provide dedicated resources for pregnancy research, including additional funding to study, disseminate, and implement interventions that optimize pregnancy outcomes.Industry and other private funders to increase support for pregnancy research and work collaboratively with stakeholders to optimize the health of individuals during and after pregnancy.Investigators and institutional review boards to presume, as recommended by the National Academy of Medicine, that pregnant and lactating individuals are eligible for participation in clinical studies.Federal agencies to require investigators to provide appropriate explanation and justification for excluding pregnant and postpartum individuals from their research.Federal agencies to require pregnancy-focused studies.Federal and private programs to support training the next generation of maternal health researchers and physician-scientists.Expanding access to research by including pregnant and postpartum individuals from diverse backgrounds and access points, including from urban and rural communities. These critical steps are required to provide an evidence base for practice that will advance meaningful change in obstetric practice and improve maternal and pregnancy-related health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.